logo
搜索
菜单

***pliance的搜索结果

当前1/2页
排序: 最近更新
1.2: Defining Social Psychology 01:09 min
1.2: Defining Social Psychology
Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models 10.3791/3981-v
Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
21.3: Cardiomyopathy III: Hypertrophic Cardiomyopathy 01:29 min
21.3: Cardiomyopathy III: Hypertrophic Cardiomyopathy
16.11: Oral Drug Delivery Systems: Introduction 01:23 min
16.11: Oral Drug Delivery Systems: Introduction
16.2: Modified-Release Drug Delivery Systems: Overview 01:19 min
16.2: Modified-Release Drug Delivery Systems: Overview
13.3: Drug Dosing: Geriatric Patients 01:15 min
13.3: Drug Dosing: Geriatric Patients
11.6: Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules 01:18 min
11.6: Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
9.5: Bioavailability Study Design: Healthy Subjects Versus Patients 01:15 min
9.5: Bioavailability Study Design: Healthy Subjects Versus Patients
Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography 10.3791/3119-v 07:51 min
Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
1.3: Physiology of Respiration I: Functions of the Respiratory System 01:27 min
1.3: Physiology of Respiration I: Functions of the Respiratory System
Elastomeric PGS Scaffolds in Arterial Tissue Engineering 10.3791/2691-v
Elastomeric PGS Scaffolds in Arterial Tissue Engineering
Characterization of the Isolated, Ventilated, and Instrumented Mouse Lung Perfused with Pulsatile Flow 10.3791/2690-v 10:02 min
Characterization of the Isolated, Ventilated, and Instrumented Mouse Lung Perfused with Pulsatile Flow
26.13: Factors Affecting Pulmonary Ventilation 01:19 min
26.13: Factors Affecting Pulmonary Ventilation
20.6: Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure 01:16 min
20.6: Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
19.4: Antiasthma Drugs: Leukotriene Modifiers 01:19 min
19.4: Antiasthma Drugs: Leukotriene Modifiers
3.29: Prodrugs 01:30 min
3.29: Prodrugs
3.26: Drug Dosage Regimen: Overview 01:15 min
3.26: Drug Dosage Regimen: Overview
10.15: Accountability and Responsibility of a Nurse I 01:30 min
10.15: Accountability and Responsibility of a Nurse I
10.13: Nurses’ Legal Responsibilities II 01:23 min
10.13: Nurses’ Legal Responsibilities II
10.9: Sources of Law 01:26 min
10.9: Sources of Law
返回顶部